Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Eltrombopag 50 mg in Healthy Mexican Volunteers
NCT02254434Phase 1Completed
- Sponsor
- GSK
- Start
- Aug 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of eltrombopag in Thrombocytopenia, sponsored by GSK. Primary endpoint: Composite of PK parameters for eltrombopag. Started Aug 2014; status: completed.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02254434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02254434.